| Literature DB >> 26973913 |
Karen Y Wonders1, Gabrielle Whisler2, Hallie Loy3, Brian Holt3, Kelsey Bohachek3, Robert Wise3.
Abstract
The purpose of this investigation was to determine if a structured, home-based exercise program was beneficial to reduce symptoms of chemotherapy-induced peripheral neuropathy and improve quality of life (QOL). A total of 50 women who are breast cancer survivors and are listed in the Breast Cancer Registry of Greater Cincinnati database were recruited by mail. Participants were initially asked to complete the McGill QOL questionnaire and the Leeds Assessment of Neuropathic Symptoms and Signs, before beginning a 10-week home-based exercise program. At the completion of the exercise program, subjects were asked again to complete the same two questionnaires. Pre- and post-intervention data were analyzed using a repeated measures ANOVA, at a significance level of α<0.05. Six individuals completed the investigation. Prior to the 10-week exercise program, participants described their pain as unpleasant skin sensations (Pre-HBEx, N=6), abnormally sensitive to touch (Pre-HBEx, N=6), and coming on suddenly in bursts for no apparent reason (Pre-HBEx, N=5). Following 10-weeks of exercise, participants reported experiencing less of these symptoms (Post-HBEx, N=3, 1, and 4 respectively; P=0.05). It was also determined that troublesome symptoms were significantly reduced after 10-weeks of home-based exercise (P=0.05).Entities:
Keywords: breast cancer; chemotherapy-induced peripheral neuropathy; home exercise
Year: 2013 PMID: 26973913 PMCID: PMC4768564 DOI: 10.4081/hpr.2013.e28
Source DB: PubMed Journal: Health Psychol Res ISSN: 2420-8124
Subject characteristics.
| Age (Yrs±SE) | 51.6±2.6 |
| Race | |
| Caucasian | 5 |
| African American | 1 |
| Marital Status | |
| Single | 2 |
| Separated/divorced/widowed | 0 |
| Married | 4 |
| Educational level | |
| High school | 1 |
| Some college/college degree | 4 |
| Graduate school | 1 |
| Current course of treatment | |
| Chemotherapy only | 3 |
| Radiation/chemotherapy | 5 |
| Surgery | 6 |
Exercise adherence data.
| Suggested exercise (min) | Mean pedometer steps | |
|---|---|---|
| Week 1 | 20 | 4441.7 |
| Week 2 | 30 | 6377.83 |
| Week 3 | 40 | 7844.98 |
| Week 4 | 60 | 9005.66 |
| Week 5 | 100 | 11555.87 |
| Week 6 | 100 | 11618.9 |
| Week 7 | 125 | 13543.87 |
| Week 8 | 125 | 13243.44 |
| Week 9 | 150 | 14568.94 |
| Week 10 | 150 | 14673.43 |
Figure 1.QOL Questionnaire. Level of troublesome symptoms related to peripheral neuropathy the patient has experienced over the last two days. Values are means ± SE. *P=0.05
Raw patient quality of life data.
| Subject | Pre-EX | Post-EX |
|---|---|---|
| 1 | 9 | 4.5 |
| 2 | 9 | 3 |
| 3 | 5.5 | 1 |
| 4 | 6 | 6 |
| 5 | 8 | 3 |
| 6 | 6 | 1 |
| Mean±SE | 7.25±0.3 | 3.08±0.4 |
Raw patient leeds assessment of neuropathic symptoms and signs questionnaire data.
| Subject | Unpleasant skin sensations | Abnormally sensitive to touch | Sudden bursts | |||
|---|---|---|---|---|---|---|
| Pre-EX | Post-EX | Pre-EX | Post-EX | Pre-EX | Post-EX | |
| 1 | Y | Y | Y | Y | Y | Y |
| 2 | Y | N | Y | N | Y | Y |
| 3 | Y | N | Y | N | Y | N |
| 4 | Y | N | Y | N | N | N |
| 5 | Y | Y | Y | N | Y | Y |
| 6 | Y | Y | Y | N | Y | Y |
| Total yes | 6 | 3 | 6 | 1 | 5 | 4 |